Defining diagnostic brain MRI markers in early MSA

Slides:



Advertisements
Similar presentations
Sporadic ataxia and multiple system atrophy Sid Gilman MD Department of Neurology University of Michigan.
Advertisements

Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.
Yujun Guo Kent State University August PRESENTATION A Binarization Approach for CT-MR Registration Using Normalized Mutual Information.
Public Health Julie C. Chapman, PsyD Director of Neuroscience War Related Illness & Injury Study Center Veterans Affairs Medical Center, Washington, DC.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Dementia with Lewy Bodies
Surgical Outcome Prognosis for the Patients with Degenerative Lumbar Spine Disease Y.I. Zhuravlev, G.I. Nazarenko, A.M. Cherkashov, V.V. Ryazanov, A.G.
A 62-year-old man with progressive action tremor and a 74-year-old man with progressive ataxia Teaching NeuroImages Neurology Resident and Fellow Section.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Parkinson’s Plus By: Glen Estrosos.
Diagnosing Mental Disorders- The Multiaxial Approach
Analyzing the Potential of a Diagnostic Tool for PD Ben Oren, Ezra Brettler, Uri Ron, and Ying Wang MKTG
CU-1 Summary of Neuropathological and Clinical Features of PDD Clive Ballard, MD Professor of Age Related Diseases Institute of Psychiatry King’s College.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Oregon Health & Science University and Northwest PADRECC
1 Junji Moriya1, Shingo Kakeda1, Johji Nishimura1, Tetsuya Yoneda2, Toru Sato1, Yasuhiro Hiai2, Norihiro Ohnari1, Okada Kazumasa3, Haruki Hayashi4, Eiji.
Golgi Protein-73 Shows Promise as a Sensitive Serum Marker for HCC Slideset on: Marrero J, Romano P, Nikolaeva O, et al. GP73, a resident golgi glycoprotein,
Wolfram Syndrome: Classic Imaging Findings of an Uncommon Disease Eric Carolan, MD Jonathan M Morris, MD Control #1520 Poster EE-12.
Putative Neural Substrates of Social Cognition in Adults with Autism
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
ULTRASONOGRAPHY AND MR IMAGING IN PROGRESSIVE SUPRANUCLEAR PALSY
NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D. 
Longitudinal course of cognition in elderly subjects with Mild Parkinsonian Signs Stefanie Lerche1,2, Kathrin Brockmann1,2, Andrea Pilotto1,3, Isabel Wurster1,2,
Muscle ultrasound as a diagnostic tool in
Multiple source current steering – A novel deep brain stimulation concept for customized programming in a Parkinson's disease patient  Michael T. Barbe 
The need for the assessment of hearing loss as part of the dementia diagnosis Jenna Littlejohn Department of Neuroscience.
PPMI in the Medical Literature
Erik K. St Louis, MD, MS, Bradley F. Boeve, MD  Mayo Clinic Proceedings 
Cryptococcosis—the impact of delay to diagnosis
J. Eric Ahlskog, PhD, MD  Mayo Clinic Proceedings 
Volume 14, Issue 1, Pages (January 2015)
CSF αlpha-synuclein is not a good diagnostic and progression marker (alone)
Evaluation of Proteinuria
HERBERT C. RUCKLE, M. D. , GEORGE G. KLEE, M. D. , PH. D. ,, JOSEPH E
Medically Unexplained Neurologic Symptoms: A Primer for Physicians Who Make the Initial Encounter  Ashley Evens, BS, Lindsay Vendetta, BS, Kaitlin Krebs,
THALASSEMIA MINOR DIAGNOSTICS BY A COMPUTATIONAL METHOD
Peripheral Arterial Disease: Diagnosis and Management
Erik K. St Louis, MD, MS, Bradley F. Boeve, MD  Mayo Clinic Proceedings 
A Network Diffusion Model of Disease Progression in Dementia
Detecting Gray Matter Maturation via Tensor-based Surface Morphometry
What are Psychological Disorders?
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Figure 2 Precision medicine based on a network approach
The “Spiked Helmet” Sign: A New Electrocardiographic Marker of Critical Illness and High Risk of Death  Laszlo Littmann, MD, PhD, Michael H. Monroe, MD 
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
Figure 4 Flow chart of the MDS MSA Study Group aims
Adnan Custovic, MD, PhD, Hans-Joachim Sonntag, MRes, Iain E
Figure 2 Diagnostic scheme for MSA
Extraocular Muscle Compartments in Superior Oblique Palsy
DAT Imaging in a cohort of p.A53T SNCA PD patients versus typical PD
Volume 85, Pages (August 2018) Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy  Giuseppe Plazzi, MD, PhD, Heather.
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
NEUROIMAGING FINDINGS OF RARE NEURODEGENERATIVE DISEASES RELATED TO DEMENTIA SYMPTOMS INTRODUCTION: Neurodegenerative diseases are diversified group of.
SYSTEMATIC REVIEW OF COMPUTATIONAL MODELS FOR BRAIN PARCELLATION
Abnormal Psychology Chapter 8
A new approach to ovarian reserve testing
Hello, my name is Attakias and today I will be presenting a study on…
NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D. 
Early detection of psychosomatic
Alan Bonder, MD, Nezam H. Afdhal, MD 
Cormac McCarthy, MD, PhD, Brenna Carey, PhD, Bruce C. Trapnell, MD 
Dementia and Cerebrovascular Disease
supported study by Dr. Heiko Gaßner and Dr. Cecilia Raccagni
Acute and Chronic Seizures in Patients Older Than 60 Years
NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D. 
Roshan Sebastian MBBS,1 William K
Representativeness of linked cancer registry and dispensed prescription data as compared with cancer registry data alone, by key patient and tumour characteristics.
Presenter: Donovan Orn
Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis The rate.
Presentation transcript:

Defining diagnostic brain MRI markers in early MSA Florian KRISMER, MD, PhD Department of Neurology Medical University Innsbruck Austria

Early diagnosis of MSA – an unmet need Due to overlapping symptoms, particularly in early disease stages, MSA is often misdiagnosed as Parkinson’s disease or other related disorders Current diagnostic criteria rely primarily on clinical symptoms and physical examination.

Study design Development of a novel MR brain atlas for automated segmentation by manually labelling relevant brain regions in 48 healthy individuals. Evaluate the diagnostic accuracy of the novel atlas for the differential diagnosis of MSA (parkinsonian and cerebellar variant) versus Parkinson’s disease in a cross-sectional study.

Key findings I – Automated Segmentation of the MCP Three‐dimensional models of automatically segmented middle cerebellar peduncles (in red/orange) in a PD patient (a) and a MSA‐C patient (b). Krismer et al.; Movement Disorders, Volume: 34, Issue: 7, Pages: 1041-1048, First published: 28 March 2019, DOI: (10.1002/mds.27669); https://doi.org/10.1002/mds.27669

Key findings II - Brain atrophy profile Data points above or to the right side of the red dotted lines indicate significant brain atrophy (as compared with age-matched healthy controls) Krismer et al.; Movement Disorders, Volume: 34, Issue: 7, Pages: 1041-1048, First published: 28 March 2019, DOI: (10.1002/mds.27669); https://doi.org/10.1002/mds.27669

Key findings III – Diagnostic algorithm Exploiting this algorithm 96.8% of MSA patients and all PD patients were classified correctly. Krismer et al.; Movement Disorders, Volume: 34, Issue: 7, Pages: 1041-1048, First published: 28 March 2019, DOI: (10.1002/mds.27669); https://doi.org/10.1002/mds.27669

Conclusions Our automated morphometric analysis corroborates previous neuropathological studies that showed that most MSA patients have a mixed striatonigral and olivopontocerebellar pathology and that brain atrophy patterns do not necessarily correspond to the clinical impression of predominant motor deficits. Automated subcortical brain segmentation accurately discriminates MSA from PD patients. The full paper is freely available from https://doi.org/10.1002/mds.27669

Acknowledgments We are grateful to for a grant in 2015 supporting this and other related projects.